Alveus
alveustx.com
Actively hiring
Cardiometabolic Therapeutics
Prescription Drugs
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$160M
1 round on record
Latest round
$160M
Venture round · Jan 2026 · 8 mo ago
Team
50–99
French register · Dec 2023
Backers
1
Jeito Capital
The money's age
Fresh money
8 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2026 | $160M | — | reuters.com |
Registers and programsofficial lists and records that name the company
| Legal entity | ALVEUS | recherche-entreprises |
| Registered | 1 Aug 2014 |
Backed byfrom the funds' portfolios and accelerator catalogs
Jeito Capital Similar startupsby what they do, their industry and backers
DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology…
Yazen is a digital weight loss service that combines medicine with diet, exercise and mental health support. The app is available for…
Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular…
COMPANY Now is the time for surgical therapeutics Peptilogics is a clinical stage company advancing its lead engineered peptide, zaloganan…
Our team has extensive expertise in kidney disease, targeted delivery of RNA therapeutics, translational systems biology and data sciences…
Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Our approach enables selective modulation…
News
Alveus Therapeutics Initiates Phase 2 PRESERVE Trial to Evaluate ALV-100 for Chronic Weight Management
Read more
Report
Alveus Therapeutics: $197 Million Series A Raised To Advance Next-Generation Obesity And Metabolic Disease Therapies
Alveus Therapeutics announced the second and final closing of its oversubscribed Series A financing, increasing the total round size to $197 million. The clinical-stage biotechnology company, which is developing next-generation therapies for obesity and m
Read more
Report
Pro access
Upgrade to see all 17 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Paris
France
HQ
10-50 est. staff
Financials
Total raised
$160M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $160M | Details |